MedElevator Войти в исследования
← Поиск публикаций

DOI 10.7150/jca.58154

Медицинская библиотека · Journal of Cancer · 2021

Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer.

Takashima Yusuke, Komatsu Shuhei, Nishibeppu Keiji, Kiuchi Jun, Ohashi Takuma, Shimizu Hiroki, Arita Tomohiro, Yamamoto Yusuke, Konishi Hirotaka, Morimura Ryo, Shiozaki Atsushi, Kuriu Yoshiaki, Ikoma Hisashi, Kubota Takeshi, Fujiwara Hitoshi, Okamoto Kazuma, Otsuji Eigo

СтатьяПеревод в очереди

Аннотация

Background

Adjuvant chemotherapy (AC) following curative gastrectomy for stage II/III gastric cancer (GC) is recommended in Japan. However, for various reasons, patients cannot always start AC at the appropriate time. This study was designed to investigate the effect of the postoperative interval until adjuvant chemotherapy (PIAC) and cumulative S-1 dose on prognosis.

Methods

Between 2008 and 2014, consecutive 81 GC patients who underwent postoperative S-1 monotherapy were enrolled in this study.

Results

Postoperative complications of Clavien-Dindo grade II or higher and postoperative peak C-reactive protein of 8.1 mg/dl or higher were significantly associated with delayed AC. The cut-off value of PIAC selected to most effectively stratify prognosis was 7 weeks. For relapse-free survival (RFS), patients with PIAC ≥ 7 weeks had an insignificantly poorer prognosis than those with PIAC < 7 weeks. A multivariate analysis showed that PIAC ≥ 7 weeks [p = 0.024; hazard ratio (HR) 2.45] and the cumulative S-1 dose/body surface area (BSA) ≥ 12,000 mg/m2 [p = 0.004; HR 3.27] were independent prognostic factors. In patients with the cumulative S-1 dose/BSA ≥ 12,000 mg/m2, there were no prognostic differences between patients with and without PIAC ≥ 7 weeks.

Conclusions

Seven weeks after surgery could be a limit indicator starting AC. A cumulative S-1 dose/BSA of more than 12,000 mg/m2 might be a key dose for diminishing the poor prognostic effects of delaying AC.

Для цитирования: Takashima Yusuke, Komatsu Shuhei, Nishibeppu Keiji, Kiuchi Jun, Ohashi Takuma, Shimizu Hiroki, Arita Tomohiro, Yamamoto Yusuke, Konishi Hirotaka, Morimura Ryo, Shiozaki Atsushi, Kuriu Yoshiaki, Ikoma Hisashi, Kubota Takeshi, Fujiwara Hitoshi, Okamoto Kazuma, Otsuji Eigo. Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer.. Journal of Cancer. 2021. DOI: 10.7150/jca.58154.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.